The EGFR variant III (EGFRVIII), formed by the deletion of exons 2–7, is the most common EGFR variant in high-grade gliomas and results in a constitutively active kinase whose activity is independent of ligand binding [18,19]. This evidence concerns the gene EGFR and central nervous system cancer.